The results showed that BDNF-induced migration and invasion ability, as well as MMP-1 up-regulation of chondrosarcoma cells, were greatly reduced by pretreatment with the ASK1 inhibitor thioredoxin [30] (Figure 4A–E). Here, TXN is linked to chondrosarcoma.